Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-30 COHEN MARC A Director Exercise or conversion +8,042 $0.61 $5K 525,746
2020-01-30 COHEN MARC A Director Exercise or conversion +16,691 $0.61 $10K 542,437
2020-01-30 COHEN MARC A Director Exercise or conversion +21,827 $3.37 $74K 564,264
2020-01-30 COHEN MARC A Director Exercise or conversion +20,778 $3.37 $70K 585,042
2020-01-30 COHEN MARC A Director Exercise or conversion +20,778 $3.37 $70K 605,820
2020-01-30 COHEN MARC A Director Exercise or conversion · Stock Option −8,042 12,063
2020-01-30 COHEN MARC A Director Exercise or conversion · Stock Option −16,691 50,072
2020-01-30 COHEN MARC A Director Exercise or conversion · Stock Option −21,827 32,918
2020-01-30 COHEN MARC A Director Exercise or conversion · Stock Option −20,778 0
2020-01-30 COHEN MARC A Director Exercise or conversion · Stock Option −20,778 0
2019-12-30 Lucchino David L. President and CEO Exercise or conversion +36,590 $0.61 $22K 444,441
2019-12-30 Lucchino David L. President and CEO Exercise or conversion +20,787 $0.61 $13K 465,228
2019-12-30 Lucchino David L. President and CEO Exercise or conversion · Stock Option −36,590 50,866
2019-12-30 Lucchino David L. President and CEO Exercise or conversion · Stock Option −20,787 310,647
2019-12-03 Lucchino David L. President and CEO Grant or award · Stock Option +96,361 96,361
2019-12-03 COHEN MARC A Director Grant or award · Stock Option +20,778 20,778
2019-12-03 Loose Christopher R. Chief Scientific Officer Grant or award · Stock Option +64,241 64,241
2019-12-03 LeBel Carl Chief Development Officer Grant or award · Stock Option +23,555 23,555
2019-10-07 Alexandria Venture Investments, LLC 10% owner Conversion +956,175 956,175
2019-10-07 Alexandria Venture Investments, LLC 10% owner Conversion · Series A Convertible Preferred Stock −4,161,974 0

Page 32 of 34 · 670 trades